ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

CUSIP: H0036K147

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding
124,261,423
Total 13F shares
67,952,003
Share change
+13,200,122
Total reported value
$182,114,158
Put/Call ratio
111%
Price per share
$2.68
Number of holders
84
Value change
+$35,606,077
Number of buys
30
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q2 2025

As of 30 Jun 2025, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,952,003 shares. The largest 10 holders included Redmile Group, LLC, Prosight Management, LP, Point72 Asset Management, L.P., ORBIMED ADVISORS LLC, BlackRock, Inc., MORGAN STANLEY, HEIGHTS CAPITAL MANAGEMENT, INC, Nantahala Capital Management, LLC, BANK OF AMERICA CORP /DE/, and GOLDMAN SACHS GROUP INC. This page lists 84 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.